FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297102747> ?p ?o ?g. }

• W4297102747 endingPage "273" @default.
• W4297102747 startingPage "263" @default.
• W4297102747 abstract "In all giant-cell-rich lesions (GCRL) occurring in bone, a common underlying excessive RANKL expression is held responsible for the osteolytic activity. Apart from giant cell tumour of bone (GCTB), systematic outcome analysis of RANKL inhibition in other GCRL is unavailable. The aim of this study is to assess the efficacy and safety of a 1-year denosumab protocol in giant cell lesions of the jaw (GCLJ).A retrospective cohort study was conducted compromising patients treated with a 1-year protocol of monthly subcutaneously administered 120 mg denosumab. Objective tumour response based on histology and imaging was used to calculate objective tumour response rate, progression-free survival (PFS) and time to progression. Type, severity and frequency of adverse events were recorded in a standardised way to assess safety.Twenty patients, predominantly female (90%), were included. Fifty-five per cent of lesions were located in the mandible; most classified as aggressive lesions (90%). Thirty-five per cent (7/20) of cases were either recurrent after prior treatment or progressive, while on other drug treatment. Objective tumour response rate was 100% after 12 months of treatment. Median PFS was 50.4 months (95% CI 38.0-62.8) with a cumulative PFS rate of 22.6% (95% CI 1.8-43.4) at 5 years follow-up. Median time to progression was 38.4 months (95% CI 26.0-50.8). Treatment was well tolerated, and none of the patients had to interrupt therapy for toxicity.High-dose denosumab is effective and safe in achieving a complete response in GCLJ within 12 months. The high long-term relapse rate after treatment cessation is the main obstacle for denosumab to become standard treatment for GCLJ." @default.
• W4297102747 created "2022-09-27" @default.
• W4297102747 creator A5007237048 @default.
• W4297102747 creator A5010615884 @default.
• W4297102747 creator A5013578265 @default.
• W4297102747 creator A5025010474 @default.
• W4297102747 creator A5032909516 @default.
• W4297102747 creator A5039900950 @default.
• W4297102747 creator A5045570938 @default.
• W4297102747 creator A5061811601 @default.
• W4297102747 creator A5062301631 @default.
• W4297102747 creator A5069712057 @default.
• W4297102747 creator A5069899921 @default.
• W4297102747 creator A5079792059 @default.
• W4297102747 creator A5083722206 @default.
• W4297102747 creator A5085973229 @default.
• W4297102747 creator A5086710202 @default.
• W4297102747 creator A5086882002 @default.
• W4297102747 creator A5088233346 @default.
• W4297102747 date "2022-11-01" @default.
• W4297102747 modified "2023-10-18" @default.
• W4297102747 title "RANKL inhibition for giant cell lesions of the jaw: A retrospective cohort analysis" @default.
• W4297102747 cites W1506243110 @default.
• W4297102747 cites W1518576821 @default.
• W4297102747 cites W1980990779 @default.
• W4297102747 cites W1994779874 @default.
• W4297102747 cites W2002731376 @default.
• W4297102747 cites W2014293036 @default.
• W4297102747 cites W2014608686 @default.
• W4297102747 cites W2017845136 @default.
• W4297102747 cites W2020448033 @default.
• W4297102747 cites W2028541032 @default.
• W4297102747 cites W2046260623 @default.
• W4297102747 cites W2046919639 @default.
• W4297102747 cites W2056155872 @default.
• W4297102747 cites W2069442595 @default.
• W4297102747 cites W2076257942 @default.
• W4297102747 cites W2123534406 @default.
• W4297102747 cites W2132904210 @default.
• W4297102747 cites W2159152276 @default.
• W4297102747 cites W2164211886 @default.
• W4297102747 cites W2169263779 @default.
• W4297102747 cites W2324825062 @default.
• W4297102747 cites W2559953844 @default.
• W4297102747 cites W2595600314 @default.
• W4297102747 cites W2623111477 @default.
• W4297102747 cites W2757719058 @default.
• W4297102747 cites W2898541498 @default.
• W4297102747 cites W2916285355 @default.
• W4297102747 cites W2921211763 @default.
• W4297102747 cites W2949454644 @default.
• W4297102747 cites W2950738816 @default.
• W4297102747 cites W2983489711 @default.
• W4297102747 cites W3087907799 @default.
• W4297102747 cites W3094293285 @default.
• W4297102747 cites W3124184062 @default.
• W4297102747 cites W3128388187 @default.
• W4297102747 cites W3132204308 @default.
• W4297102747 cites W3138945788 @default.
• W4297102747 cites W3167341463 @default.
• W4297102747 cites W4210742563 @default.
• W4297102747 doi "https://doi.org/10.1016/j.ejca.2022.08.011" @default.
• W4297102747 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36174298" @default.
• W4297102747 hasPublicationYear "2022" @default.
• W4297102747 type Work @default.
• W4297102747 citedByCount "3" @default.
• W4297102747 countsByYear W42971027472022 @default.
• W4297102747 countsByYear W42971027472023 @default.
• W4297102747 crossrefType "journal-article" @default.
• W4297102747 hasAuthorship W4297102747A5007237048 @default.
• W4297102747 hasAuthorship W4297102747A5010615884 @default.
• W4297102747 hasAuthorship W4297102747A5013578265 @default.
• W4297102747 hasAuthorship W4297102747A5025010474 @default.
• W4297102747 hasAuthorship W4297102747A5032909516 @default.
• W4297102747 hasAuthorship W4297102747A5039900950 @default.
• W4297102747 hasAuthorship W4297102747A5045570938 @default.
• W4297102747 hasAuthorship W4297102747A5061811601 @default.
• W4297102747 hasAuthorship W4297102747A5062301631 @default.
• W4297102747 hasAuthorship W4297102747A5069712057 @default.
• W4297102747 hasAuthorship W4297102747A5069899921 @default.
• W4297102747 hasAuthorship W4297102747A5079792059 @default.
• W4297102747 hasAuthorship W4297102747A5083722206 @default.
• W4297102747 hasAuthorship W4297102747A5085973229 @default.
• W4297102747 hasAuthorship W4297102747A5086710202 @default.
• W4297102747 hasAuthorship W4297102747A5086882002 @default.
• W4297102747 hasAuthorship W4297102747A5088233346 @default.
• W4297102747 hasBestOaLocation W42971027471 @default.
• W4297102747 hasConcept C126322002 @default.
• W4297102747 hasConcept C141071460 @default.
• W4297102747 hasConcept C143998085 @default.
• W4297102747 hasConcept C167135981 @default.
• W4297102747 hasConcept C170493617 @default.
• W4297102747 hasConcept C197934379 @default.
• W4297102747 hasConcept C2776286101 @default.
• W4297102747 hasConcept C2776541429 @default.
• W4297102747 hasConcept C2777251235 @default.
• W4297102747 hasConcept C2777556957 @default.
• W4297102747 hasConcept C2779428903 @default.

• next